Focus: 68th AACC Annual Scientific Meeting & Clinical Lab Expo

• share
• favorite_border

A team of researchers has demonstrated that children with autism spectrum disorder have a unique composition of gut bacteria and urinary metabolites compared with unaffected children. The research, revealed today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, could lead to promising new treatment options for children with autism as well as earlier detection of the disorder.

• share
• favorite_border

Reproductive health is not the same as sex ed,” Teresa K. Woodruff, PhD, from the Feinberg School of Medicine, Northwestern University, reminded us in yesterday’s plenary session, “Oncofertility: From Bench to Bedside to Babies.” The war on cancer has been hard fought, with more young women than ever now surviving cancer but being faced with the possibility of infertility.

• share
• favorite_border

Anyone who walked into Monday’s morning symposium, “Novel Psychoactive Substances (NPS) in Emergency Toxicology” thinking that NPS are not a growing threat to public health were quickly disavowed of that notion. Speakers Jennifer Colby, PhD, and Kai Li, MD, described various compounds, including the drug U-47700, which is a synthetic super-opioid that causes extreme euphoria and respiratory depression, frequently leading to adverse effects, including death.

• share
• favorite_border

The 2017 AACC Annual Meeting Organizing Committee accepted 740 abstracts representing innovative scientific work from more than a dozen countries. Although every abstract will not receive distinguished recognition from the AACC Academy or the various AACC Divisions, highlighted here are several interesting studies that you may want to visit during this year’s poster sessions. Posters are located in the upper level of the Sails Pavilion in the San Diego Convention Center.

• share
• favorite_border

The amount of information gathered via next-generation sequencing has made the diagnosis of genetic disorders quicker and more accessible to clinicians than ever before, but with expanded testing options come questions about ordering the correct type of testing.

• share
• favorite_border

Some say that the invention of the abacus more than 2,500 years ago was the first step on the long road to artificial intelligence (AI). The reason why this simple calculator made of beads and wires is often called the precursor to the modern computer is because the principle—performing repeated calculations faster than the human brain—is the same. Now scientists are harnessing the speed of modern computers and programming them with cognitive algorithms and sophisticated decision trees to help solve complex medical problems. This rapidly advancing science was the focus yesterday of the Chair’s Invited Session, “Is Artificial Intelligence in Genomics Ready for Prime Time?”

• share
• favorite_border

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

• share
• favorite_border

Researchers have shown that a new genetic test could potentially help stem the tide of the opioid epidemic by predicting which patients are at risk of abusing prescription opioids. These findings were presented for the first time at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

• share
• favorite_border

A new study shows that a change in policy placing more restrictions on all hydrocodone-containing drugs has successfully decreased the use of certain opioids such as Vicodin. This research and a second study illuminating regional drug use trends in Canada were announced today at the 69th AACC Annual Scientific Meeting in San Diego, and could help to guide future strategies for combatting addiction.

• share
• favorite_border

A new study has discovered that two microRNAs could be used to develop the first-ever blood test for kidney cancer as well as novel treatments for this condition. These findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

• share
• favorite_border

AACC is pleased to announce the recipients of the AACC 2017 Top Corporate Supporter Awards. This year, AACC recognizes 46 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

• share
• favorite_border

At the 69th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 30–August 3 in San Diego, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore transforming biology using CRISPR engineering and new applications for DNA sequencing; preserving fertility in young people with cancer; how clinical testing can help solve public health crises; and a session that uncovers the precision diagnostics that are creating a digital health revolution.

• share
• favorite_border

Tutela Monitoring Systems has your solution to mobile cold chain protection

• share
• favorite_border

AACC welcomed thousands of medical professionals and healthcare leaders at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia from July 31–August 4. The meeting featured pioneering advances in medical testing research and technology that will help patients get accurate diagnoses and more effective treatment. As of Wednesday, August 3, a total of 20,000 laboratory medicine professionals had registered for the meeting, which is a 14% increase over meeting attendance in 2015 and the highest number of attendees that have come to the meeting in the last four years. More attendees are expected today, the last day of the meeting.

• share
• favorite_border

The Tutela Genesis II Temperature Monitoring System is the most intuitive and robust system yet from Tutela. Find out why so many have chosen Tutela to monitor their priceless inventory.

• share
• favorite_border

Beckman Coulter Addresses Critical Factors for Clinical Laboratories to Move Healthcare Forward

• share
• favorite_border

GlycoMark, Inc. announced it has partnered with Diazyme Laboratories to offer the first diabetes panel to test three different measures of glycemic control on one specimen. The panel includes assays that measure both intermediate-term and long-term glucose averages (Diazyme’s Glycated Serum Protein/GSP and Enzymatic HbA1c) along with GlycoMark—a test specifically related to hyperglycemia over a one- to two-week period. The announcement was made at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo.

• share
• favorite_border

The first of its kind alliance provides Augusta University’s medical center with unprecedented access to the full suite of diagnostic products and world-class business services available from Beckman Coulter’s parent company, Danaher Corporation.

• share
• favorite_border

With increasing public attention to overdose deaths and misuse of prescription medications in the United States, researchers today presented the results of a new study looking at abuse and misuse of gabapentin, a medication used to treat seizures and relieve nerve pain often associated with shingles.

• share
• favorite_border

Researchers today unveiled results from a new blood test to help identify which patients are at an elevated risk of Alzheimer’s disease. The findings, presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, showed that the biochip test, which allows multiple tests to be run on one blood sample, was as accurate as existing molecular tests that analyze DNA.

• share
• favorite_border

Research announced today at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that a first-of-its-kind next-generation sequencing test can detect HIV drug resistance mutations that conventional tests fail to identify. This test could play a critical role in helping clinicians to optimize HIV treatment regimens, while also helping public health initiatives to minimize the development of global resistance to antiretroviral drugs.

• share
• favorite_border

This product allows you to test different particles to find which yield optimal performance characteristics in your specific system including cell isolations, affinity purifications, immunoassays, molecular assays.

• share
• favorite_border

Researchers have successfully tested a new method for the early diagnosis in children and teenagers of diabetic nephropathy, a serious complication of diabetes that can increase risk of death. This new method, unveiled today at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo, would help pediatric patients get necessary treatment in a more timely manner.

• share
• favorite_border

AutoSorter™ 1200 is Yaskawa Motoman’s newest high-speed sorting instrument for pre- and post-analytic specimen processing. Leveraging the previous model’s excellent record for reliability and speed, AutoSorter 1200 raises the bar on throughput at up to 1,200 tubes/hr.

• share
• favorite_border

Yaskawa Motoman’s AutoSorter™ 2000BB bulk sorter has a new configuration available that can maintain frozen specimens in a -20°C environment during the sorting process. This enables automated sorting of most frozen specimens which previously required labor-intensive and error-prone manual handling.

• share
• favorite_border

AACC is pleased to announce the recipients of the AACC 2016 Corporate Supporter Awards. This year, AACC recognizes 47 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

• share
• favorite_border

The 68th AACC Annual Scientific Meeting & Clinical Lab Expo is where the future of laboratory medicine and patient care comes into view. This year, late-breaking sessions will deliver insights into the latest advances that are transforming healthcare, including gene editing with CRISPR, the use of drones to transport patient samples in remote areas, and efforts to end the hepatitis C epidemic.

• share
• favorite_border

Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests. This cell-free DNA test could help liver transplant patients receive crucial treatment for rejection faster, and has the potential to improve the prognosis of kidney and heart transplant patients as well.

• share
• favorite_border

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) sets global standard in collaboration with other international organizations as harmonization of methods in laboratory medicine is a means to improve patient safety

• share
• favorite_border

eAcademy aims to make high quality educational modules available to Laboratory professionals and will provide a resource for individuals in their training, as well as for those involved in the planning and organisation of educational programmes.

• share
• favorite_border

At the 68th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 31–August 4 in Philadelphia, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore the latest research on cannabis use, reducing premature death worldwide, and innovations such as the programmable bio-nano-chip and “intelligent” surgical knife.

• share
• favorite_border

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) as leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide, strives to enhance the scientific level and the quality of diagnosis and therapy for patients throughout the world.

• share
• favorite_border

Based on the proven ASP sample processing platform extended with a specially designed card handler addcare provides an automated solution for Gel Card based applications.

• share
• favorite_border

AUDIT MicroControls, Inc. is pleased to announce the following new addition to our complete line of calibration verification/linearity and daily quality control products: Linearity FD BNP (Extended). This product is intended to simulate human patient serum samples for the purpose of determining linearity, calibration verification and verification of reportable range.

• share
• favorite_border

Awareness Technology, manufacturer of diagnostic ELISA, CLIA, Biochemistry, and ISE instruments and reagents announces the restructuring of its UAE branch office to improve access for all Asian markets.

• share
• favorite_border

Addcare Bio-Tech provides advanced liquid handling systems, automated immunoassay workstations and customized systems. We create solutions for a wide range of applications by combining our proprietary liquid handling technology with a variety of platforms and modules, each designed to handle a specific task in the configuration.

• share
• favorite_border

Awareness Technology, manufacturer of diagnostic ELISA, CLIA, Biochemistry, and ISE instruments and reagents, completed the development of ChemWell® 2. The new analyzer represents an evolution of the ChemWell® line of fully automated instruments applying the company’s innovative single-plate technology to a two-plate system. Unlike similar devices capable of processing both ELISA and CLIA assays in 96-well micro plates, ChemWell®2 offers increased flexibility to laboratory professionals by allowing random placement of ELISA and CLIA microstrips even within the same plate.

• share
• favorite_border

Awareness Technology, manufacturer of diagnostic ELISA, CLIA, and Biochemistry instruments and reagents announces the worldwide launch of a new analyzer for measuring serum concentrations of sodium, potassium and chloride as a companion product to its line of biochemistry analyzers. Selectalyte, which is available both as a stand-alone instrument and as a module, was developed after many years of working with other similar devices and incorporating a number of significant improvements to ease of use, electrode stability, overall durability, precision, and convenience. The instrument and all its consumables, including a tri-level set of controls, are manufactured at Awareness Technology.

• share
• favorite_border

Biomatrica, Inc., a producer of reagents and devices for sample collection and analysis in diagnostics systems, nucleic acid testing, and biobanking, announced today that it has received certification from British Standards Institution Group America, Inc. that the company complies with the requirements of ISO 13485:2003 for an integrated quality management system across all functions of the business, from design and development to manufacturing and supply.

• share
• favorite_border

Boule Diagnostics AB has won a significant share of public tenders for a total of 329 hematology systems in Mexico in partnership with its Mexican distributors. The instruments will be delivered at the end of the second quarter and beginning of third quarter 2016. Some smaller follow-up orders are expected during the third quarter. The purchasing organisations have been IMSS (Instituto Mexicano del Seguro Social), the largest and most important public health system in the country, and ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado), the second largest public system in charge of providing health services to government employees.

• share
• favorite_border

Compact KNF boxer diaphragm pumps feature an efficient two-heads-one-motor configuration. The alternating head operation results in smooth, level flow, reducing the need for additional dampening components for systems sensitive to pulsation. In an alternative mode, two different liquids are transferred simultaneously, eliminating the need for a second pump.

• share
• favorite_border

KNF Neuberger introduces the “Big Sucker diaphragm pump, a high flow pump specifically designed for liquid/air mixture applications, such as emptying well plates and waste-liquid containers.

• share
• favorite_border

Quiet, compact KNF Micro gas diaphragm pumps offer durable solutions for aspiration, waste-handling, anesthesia monitoring, tissue sampling, blood pressure gauges, negative wound therapy, and cleaning applications.

• share
• favorite_border

Maccura Biotechnology Co., Ltd. was incorporated in 1994. It focuses on In-Vitro Diagnostic reagents’ development, manufacture, marketing and service. Maccura is a hi-tech enterprise certified by relevant departments. Maccura has past the CMD ISO13485, CQC ISO14001, TUV ISO13485 as well as CE Certification of some products, and obtained the CNAS Medical Reference Laboratory Accreditation.

• share
• favorite_border

We are participating 68th(2016) AACC Annual Scientific Meeting and Clinical Lab Expo in Pennsylvania convention center, Philadelphia. PA. USA. during August 2~4 and we will have a special presentation for press conference. This opportunity is given to the reputed companies and our products.

• share
• favorite_border

Featured Surmodics product at AACC 2016

• share
• favorite_border

Ortho Clinical Diagnostics will present seven scientific posters on its assays and display six products at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. Ortho’s posters will address a range of important tests, both marketed and in-development for clinical labs.

• share
• favorite_border

Puritan is pleased to announce that the German Patent and Trademark Office (GPTO) has handed Puritan and its customers a win in cancellation proceedings initiated on Puritan’s behalf against Copan’s utility model DE 20 2004 021 932 U1 (DE’932). Specifically, in DE File No. 20 2004 021 932.8, the GPTO has declared DE’932 invalid for its entire term, effectively erasing the patent as if it never existed. This means Copan may not base any claims on any alleged infringement of DE’932.

• share
• favorite_border

On June 3rd, 2015, in the oral hearing before the Board of Appeals of the European Patent Office (EPO), the EPO has issued its final decision regarding Copan’s European Patent EP 1 608 268 B1 (“EP’268”). The Board of Appeals of the EPO confirmed that Copan’s EP’268 is only valid in a scope which is substantially narrower than the claim set as originally granted.

• share
• favorite_border

Puritan Medical Products, North America’s largest manufacturer of swabs and specimen collection devices, is pleased to announce Opti-Tranz™ and Opti-Tranz™ Plus, a brand new line of traditional liquid and agar gel collection and transport systems for bacteriological applications.